Pre-Pregnancy Hypertension and Diabetes Linked to Higher Risk of Severe Fetal Heart Defects

New research finds that chronic hypertension before pregnancy is associated with a 30% higher risk of critical congenital heart disease in infants, and pre-existing diabetes with a 48% higher risk, underscoring the importance of maternal heart health before conception.

Chicago Metrowire Staff
••Healthcare
Pre-Pregnancy Hypertension and Diabetes Linked to Higher Risk of Severe Fetal Heart Defects

A new analysis of more than 44 million U.S. births reveals that women with chronic hypertension, defined as high blood pressure before pregnancy or diagnosed before 20 weeks of pregnancy, face a 30% higher risk of delivering an infant with critical congenital heart disease (CCHD) compared to women with normal blood pressure. The findings, presented at the American Heart Association’s Scientific Sessions 2026, also show that Type 1 or Type 2 diabetes before pregnancy is linked to a 48% increased risk of severe heart defects.

The study’s implications are significant given the rising prevalence of maternal hypertension, which increased by nearly 48% from 2018 to 2024, and the parallel 10% rise in CCHD cases. CCHD is the most severe form of congenital heart disease, requiring surgery or catheterization within the first year of life and ongoing specialty care. With nearly 4,000 infants affected annually in the U.S., the findings highlight an urgent need for preconception and early pregnancy monitoring.

“Our findings suggest that maternal heart health before and during pregnancy may have a particularly important relationship with fetal heart development,” said study author Saad Ur Rahman, M.D., a chief cardiology fellow at Lahey Clinic of Beth Israel Lahey Health. The study analyzed data from the CDC’s National Vital Statistics System and categorized hypertension into chronic, gestational, chronic plus gestational, and eclampsia. Gestational hypertension was associated with an 8% increased risk, while eclampsia showed no significant association.

The research adds to a growing body of evidence linking maternal health to fetal cardiovascular development. “Although the absolute risk of critical congenital heart disease remains low, these findings highlight the importance of identifying and managing chronic hypertension before and during pregnancy,” said Flora Nuñez Gallegos, M.D., M.P.H., a pediatric cardiologist at UCSF and member of the American Heart Association’s Young Hearts Council. She noted that the association was stronger for chronic hypertension than for gestational hypertension, emphasizing the importance of maternal health even before pregnancy begins.

The study’s limitations include its observational design, which cannot establish causation, and reliance on birth certificate data that lacks information on genetic factors, prenatal imaging, and blood pressure treatment. The findings are considered preliminary until published in a peer-reviewed journal. The research was presented at the American Heart Association’s premier global exchange of cardiovascular science, as detailed in the Online Program Planner, and the full abstract is available. A Spanish news release is also available.

For women with high blood pressure in pregnancy, the American Heart Association offers resources on Preeclampsia and High Blood Pressure and a fact sheet on Preeclampsia, High Blood Pressure and Maternal Health. The study authors call for future research into the biological mechanisms linking maternal hypertension to CCHD and whether risk is influenced by timing, severity, and treatment of high blood pressure.

Blockchain Registration

QR Code for Blockchain Registration